fda indications for semaglutide approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease FDA alerts health care providers,

Learn how long it's safe, what happens if you stop, and how MeAgain helps you manage weight loss for the long haul.

MeAgain is better for GLP-1-first daily tracking, shots, food, symptoms, progress, and medication context in one app.

The CHC companies that win this decade will be the ones who decide now whether GLP-1 is a #threat to defend against or a category to #shape

Choosing the right injection site for semaglutide affects how your body absorbs the medication and maintains steady therapeutic levels

Sciwind filed for an IPO on the Hong Kong Stock Exchange a few months after that Reuters report to help bankroll its sprawling pipeline